Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Ipsen

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Ipsen's 2013 oncology sales performance.

Ipsen S.A.

European Commission approves Opdivo plus Cambometyx for advanced kidney cancer

European Commission approves Opdivo plus Cambometyx for advanced kidney cancer

The European Commission (EC) has approved a combination of Bristol Myers Squibb’s (BMS) Opdivo with Ipsen’s Cabometyx for the first-line treatment of advanced renal cell carcinoma (RCC) – the ... The EC approval for Opdivo plus tyrosine kinase

Ipsen

By doing this, we strengthened Ipsen’s relevance by stripping it to its core and what matters most – business, patients and people. ... It was obvious that Ipsen have carried out a huge amount of work internally throughout 2019.

AstraZeneca Global Corporate Affairs

- - PMLiVE - PMLiVE

In-House Team of the Year

Until 2019, being seen as ‘relevant’ to key stakeholders was one of Ipsen’s biggest challenges, but we saw this as an opportunity to put the company on the map as ... By doing this, we strengthened Ipsen’s relevance by stripping it to its core

Revenue growth at Ipsen numbs pain of palovarotene calamity

Revenue growth at Ipsen numbs pain of palovarotene calamity Then, just last month, Ipsen said the drug had failed a futility test in its registrational MOVE trial, suggesting it was heading for failure. ... In the near-term, Ipsen’s late-stage R&D beyond palovarotene is focused mainly on line extensions for

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics